Header Logo

Connection

ANDREW LEE to Bevacizumab

Back to Details
This is a "connection" page, showing publications ANDREW LEE has written about Bevacizumab.
ANDREW LEE
Connection Strength
0.193
Bevacizumab
  1. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PHARMACEUTICAL UTILIZATION AND FINANCIAL IMPACT IN A VALUE-BASED CARE PROGRAM. Retina. 2023 03 01; 43(3):506-513.
    View in: PubMed
    Score: 0.193
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.